AMG Funds’s Novo Nordisk NVO Stock Holding History

AMG Funds’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-16,504	Closed	-$397K	–	115
2017 Q3	$397K	Sell	16,504 -50,150	-75%	-$1.13M	0.22%	111
2017 Q2	$1.43M	Buy	66,654 +33,484	+101%	+$676K	0.79%	71
2017 Q1	$569K	Buy	+33,170	New	+$578K	0.31%	103

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

AMG Funds's NVO Position: Q4 2017 in Review

AMG Funds sold out of Novo Nordisk (NVO) in Q4 2017, closing a stake of 16,504 shares — an estimated $397K sold.

AMG Funds first reported a position in NVO in Q1 2017 and held it in 3 quarters. The position peaked at $1.43M in Q2 2017. 552 funds tracked by Wall St. Rank hold NVO as of Q4 2017.

AMG Funds reported no remaining Novo Nordisk position as of Q4 2017 after selling out during the quarter.
AMG Funds sold 16,504 Novo Nordisk shares in Q4 2017, an estimated $397K.
AMG Funds first reported a position in Novo Nordisk in Q1 2017 and held it in 3 quarters.
AMG Funds's Novo Nordisk position peaked at $1.43M in Q2 2017.
552 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2017.

Based on AMG Funds's 13F filing for Q4 2017, filed 7 Feb 2018.